Indian investors are bracing for a busy day on November 3, as a long list of BSE500 companies – including banking giant State Bank of India (SBI) and financial services firm Bajaj Finserv – are scheduled to release their second-quarter earnings. The corporate calendar, as tracked by Reuters, shows dozens of updates, but a significant number are marked “no time scheduled” (NTS), adding an element of uncertainty to the trading session.
What does 'no time scheduled' mean?
For most earnings releases, companies specify a time – often before market open, during trading hours, or after the close. When a release is marked NTS, it means the company has not committed to a specific time. As a result, investors cannot plan around a particular moment when price-sensitive information will hit the wires. The numbers could drop at any point during the session, potentially triggering sudden moves in the stock price.
This is particularly relevant for large-cap names like SBI and Bajaj Finserv, where any surprise in profit, revenue, or asset quality can move the stock – and sometimes the broader market – in a matter of minutes. For traders, NTS adds risk; for long-term investors, it's a reminder to stay patient and avoid reacting to intraday volatility.
Who else is reporting?
Beyond the two headline names, the calendar includes a range of companies across sectors. In pharma, Lupin and GlaxoSmithKline Pharmaceuticals are among those scheduled to report. These firms are part of the BSE500 index, which tracks the top 500 companies by market capitalisation on India's Bombay Stock Exchange.
The breadth of the list – spanning banking, insurance, pharma, and other industries – means that November 3 could be a day of significant sector-specific news. For example, SBI's results will be closely watched for trends in loan growth, asset quality, and net interest margins, while Bajaj Finserv's numbers will offer insights into the health of consumer lending and insurance businesses.
Why this matters for investors
Earnings season is a critical period for stock markets, as it provides a snapshot of corporate health. For everyday investors, these reports can influence portfolio decisions, but it's important to remember that one quarter's results are just one data point. The NTS designation means you might see sharp price swings during the day, but that doesn't necessarily reflect the long-term value of the company.
If you hold shares in any of these companies, the key is to focus on the fundamentals – revenue growth, profit margins, and management commentary – rather than the timing of the release. If you're considering buying or selling, it's often wise to wait for the dust to settle after the announcement, as initial market reactions can be exaggerated.
For those watching the broader Indian market, this busy day comes amid a backdrop of global earnings season and economic data. As US stock futures edge higher on similar earnings and data flows, Indian markets are also influenced by global sentiment. Additionally, Indian stocks and the rupee have recently gained on falling oil prices, which could provide some cushion to corporate earnings.
What to watch next
Beyond the headline numbers, investors will be listening for management guidance on future quarters. In a high-interest-rate environment, commentary on demand, input costs, and credit quality will be just as important as the reported figures.
For SBI, as India's largest public-sector bank, any update on bad loans or provisioning will be scrutinised. For Bajaj Finserv, the focus will be on growth in its lending and insurance segments. Pharma companies like Lupin and GSK Pharma will be judged on their ability to maintain margins amid pricing pressures in key markets.
As the day unfolds, expect volatility, but remember that a single earnings release rarely changes the long-term trajectory of a well-run company. For a broader perspective on how earnings are shaping markets, you can also look at how other sectors are splitting winners and losers this season.
In short, November 3 is set to be a busy and potentially choppy day for Indian equities. Stay informed, but avoid making hasty decisions based on the timing of a release. The fundamentals will tell the real story.
